ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Anthera Pharmaceuticals Inc (CE)

Anthera Pharmaceuticals Inc (CE) (ANTH)

0.0001
0.00
( 0.00% )
Updated: 18:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.0002
Previous Close
0.0001
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
23,317
Financial Volume
-
VWAP
-

ANTH Latest News

Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the...

HAYWARD, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH) (โ€œAntheraโ€ or the โ€œCompanyโ€) announced today that it has withdrawn its request for a hearing to...

Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura

Sollpura did not achieve the primary endpoint of the coefficient of fat absorption (โ€œCFAโ€)Sollpura did achieve the secondary endpoint of coefficient of nitrogen absorption (โ€œCNAโ€)Further...

Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference

HAYWARD, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

Anthera Pharmaceuticals Deemed Compliant with Nasdaq Listing Criteria

HAYWARD, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticalsย (Nasdaq:ANTH) today announced that Anthera has received formal notice from The NASDAQ Stock Market LLC (โ€œNasdaqโ€...

Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results

RESULT study reported positive interim futility analyses and completion of dosing, with top line data expected in March 2018Completed private placement for net proceeds of $13.3 million...

Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference and SunTrust Robinson Humphreyโ€™s 4th Annual Orp...

HAYWARD, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura

HAYWARD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH) is pleased to announce that the final patient has completed the last visit in the primary...

Anthera Receives Positive Nasdaq Listing Determination

HAYWARD, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announcedย that on January 24, 2018, Anthera received formal notice that the Nasdaq...

Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura: Stud...

HAYWARD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced a positive outcome of the second, pre-specified interim futility analysis for...

Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering

HAYWARD, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH) today announced that it has completed the second closing of the private placement of its equity...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00010.00010.0001400000.0001CS
49.9E-599001.0E-60.00011.0E-675098.89E-5CS
12000.00010.00021.0E-6233176.293E-5CS
269.9E-599001.0E-60.00021.0E-6166706.539E-5CS
523.3E-549.25373134336.7E-50.00021.0E-6125576.02E-5CS
1569.9E-599001.0E-60.0081.0E-6156628.254E-5CS
260-0.0299-99.66666666670.030.1891.0E-6895260.04083451CS

ANTH - Frequently Asked Questions (FAQ)

What is the current Anthera Pharmaceuticals (CE) share price?
The current share price of Anthera Pharmaceuticals (CE) is US$ 0.0001
What is the 1 year trading range for Anthera Pharmaceuticals (CE) share price?
Anthera Pharmaceuticals (CE) has traded in the range of US$ 0.000001 to US$ 0.0002 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.10
(99,900.00%)
100
HAVLFHavn Life Sciences Inc (CE)
US$ 0.001
(99,900.00%)
10.12k
STTOSITO Mobile Ltd (CE)
US$ 0.0012
(59,900.00%)
500
SIRCSolar Integrated Roofing Corporation (PK)
US$ 0.0002
(19,900.00%)
5.19M
LLBOLifeline Biotech Inc (CE)
US$ 0.0002
(19,900.00%)
10k
NOKPFNok Airlines Public Company Ltd (CE)
US$ 0.0001
(-99.75%)
154.79k
NEOMNeoMedia Technologies Inc (CE)
US$ 0.000001
(-99.50%)
50.34k
IFANIFAN Financial Inc (CE)
US$ 0.000001
(-99.50%)
104k
PLPLPlandai Biotechnology Inc (PK)
US$ 0.000001
(-99.00%)
1.36M
MAPTMAPtelligent Inc (CE)
US$ 0.000001
(-99.00%)
165k
PHILPHI Group Inc (PK)
US$ 0.0005
(66.67%)
263.16M
HMBLHUMBL Inc (PK)
US$ 0.0008
(0.00%)
158.86M
RDARRaadr Inc (PK)
US$ 0.0015
(11.11%)
104.7M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0002
(100.00%)
59.02M
GTCHGBT Technologies Inc (PK)
US$ 0.0002
(0.00%)
36.01M

ANTH Discussion

View Posts
Maniana Maniana 4 years ago
I do see some selling
๐Ÿ‘๏ธ0
Dougie1128 Dougie1128 4 years ago
Gonna make a comeback any day now. Amazon is going to spinoff it's delivery service into ANTH's shell.
๐Ÿ‘๏ธ0
Mrvince Mrvince 5 years ago
I assume this stock is toast
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Wow, 7.143-Bagger Huge rally from 0.0070 to 0.05 without any good news at all! Why such strong rally?
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Why ANTH crashed to 0.023 last session (on this Monday) or a day ago? Will its New Bottom 0.0070 be tesed again very soon?
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
0.0001 very soon? Why? Anyway ANTH only crashed to 0.0070 so far!
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Yeah, do you know how much those assets could worth? Anyway ANTH has already bounced to 0.07 from 0.028! I'm wondering if it will test 0.05 ~ 0.06 again as soon as today...

๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Nice action! The Pos Scam has already crashed to $0.0070 from its recent high $0.17xx just four months ago!

๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
LOL, How could this Pos Scam crash back to 0.035 from yesterday's high 0.07 which is 50% decline without any Bad News at all?
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
ANTH crashed to 0.028 yesterday with Tens Of Thousands shares! It will test its current Bottom $0.0070 again as soon as this month though it has already bounced to 0.0700 yesterday...
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
New 52-week low 0.0070 was created! How could this Pos Scam be able to bounce 10-Bagger+ to 0.07+? Anyway it just crashed to 0.03 again... Sell ASAP since it will hit 0.01 very soon!
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Those emotional most recent 0.399 ~ 0.1 buyers are in Hyper Deep Losses now and they have to cut their Giant losses before the end of 2018 which will soon drive this Pos Scam down to 0.001 ~ 0.01 area! Very soon even those 0.0999 ~ 0.07 buyers will incur huge losses too once 0.07 is broken down!

Why a worthless junk stock is trading at $2.592M ~ $1.833M MV now? Which is ridiculous high and not sustainable because its OTC peer (such as URBF) is trading at $0.016M MV or $0.0001 a share now! Which means ANTH is 162 ~ 115 Times more expensive than its peer!
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
When the CH7 Bankruptcy is filed with ANTH we'll see 0.0001 at the end! I've been very busy to sell out all my shares (1.5M) at 0.09xx or even 0.08xx to make huge quick gain before the death spiral kicks in which will destroy ANTH to as low as 0.0010...
๐Ÿ‘๏ธ0
CarlCarlMcB CarlCarlMcB 6 years ago
.0001
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
No any value left! Worthless junk stock with a crap CEO and the worst management team! They have stolen all the potential value long time ago... I'll sell out all my remaining shares at 0.099 ~ 0.09 or even 0.08xx again if there is no way to get rid of this Pos Scam at 0.09xx...

ANTH will soon crash to 0.01 ~ 0.0010 price levels before the end of 2018...
๐Ÿ‘๏ธ0
SC777 SC777 6 years ago
They still have some pretty valuable IP and another drug in the pipeline right?

De-registration is just to cut costs. I don't own any of this, but seems like there might be value here.
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
The Form 15-12b was just filed yesterday after the market close! Which means no more filing in the future and ANTH will become a Non-Reporting OTC stock. So we should see this pos scam heading onto 0.01 or below very soon after the most recent 0.07 ~ 0.099 buyers exhaust their purchasing powers and ANTH breaks down the current bottom 0.07...
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
I bought back all my 1M+ shares at 0.07xx and sold partial shares at 0.099 ~ 0.08 most recently. Enjoy nice and easy quick gain from ANTH! Hopefully 0.07 could hold forever bottom for the shareholders!
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
I'm very glad to have made very nice initial Quick gains by selling my partial ANTH shares at 0.09xx ~ 0.08xx! I'll sell out all the remaining shares in the coming days/weeks because I'm afraid the coming Dissolution/Liquidation and Huge R/S & Diluting risks here...

I'll use all the proceeds to buy a OTCQB/NYSE stock with over 20 Times of BV/PPS ratio!
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
I'm very glad to have bought back my previous 1M+ shares at 0.07xx (I sold the previous position at 0.23 ~ 0.39 for huge profit)! Now I'm enjoying very nice initial gain and I'll flip out all the ANTH shares for another round of Quick huge gain as I did before De-Listing because I don't want to stuck with this Pos Scam when the coming Liquidation/Bankruptcy or Huge R/S kicks in...

Anyway Huge Dilutions are going-on here everyday and our ownership is shrank for each day! What a Giant Diluting Machine?
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Another New low 0.07 was created so far! Hopefully this Pos Scam won't crash to 0.01 like its similar-SS peer did most recently...

When will the on-going Huge Dilutions be ended here? When will the Big R/S kick in? Will the company file the Bankruptcy this month? Will our common shares be Worthless very soon? Why didn't the company fire both the Useless employees and the crap CEO?
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
The Pos Scam is heading onto another New low $0.0596 based on its NYSE peer (RASF: 48.125% price crash with $1.59 BV and $0.91 CV) did after de-listing from NYSE to OTCQB! Because many institution shareholders will be forced to liquidate all their common shares at any price due to its current OTC-Pink-Sheet trading status (ANTH was a Nasdaq stock)!

A Series Of New 52-week lows will be created in the coming days/weeks since the on-going Huge Sell-Off will continue...

0.04 should hold the Bottom before the bounce if no any further Very Bad news like Giant Dilutions or Huge R/S or Bankruptcy Filing! Where is the crap CEO while we need him? Will the Huge R/S or Giant Dilutions kick in as soon as next week?

Those 0.18 ~ 0.1175 buyers are in Very Deep Huge Losses now and very soon those 0.117 ~ 0.0901 buyers will be the same!

I had already flipped three times for some quick gain.

Anyway I ever warned all the buyers here: don't buy ANTH above $0.31! Those $0.399 ~ $0.3101 buyers will never recover their Giant Losses in the future!

๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Wow, ANTH crash to 0.0755 so far! Will it crash to 0.06 as soon as today? I bet 0.04 will hold the Bottom if no any further Very Bad news like Giant Dilutions or Bankruptcy Filing! Where is the crap CEO while we need him? Will the Huge R/S kick in as soon as next week?

Yesteray's 0.0117 ~ 0.0901 buyers are in Very Deep Huge Losses now...
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
The Pos Scam (ANTH) just declined to another New low $0.0901 so far! I bet another New low $0.071 will be created as soon as this week because many institution shareholders will be forced to liquidate their positions due to its current OTC-Pink-Sheet trading status...

In fact the same thing happened to its NYSE peer (RASF): the institution's sell-off lead to 48.125% huge price crash --- from its previous Bottom $0.16 (as a NYSE stock) to the current new Bottom $0.083 (as a OTCQB stock)! Thus ANTH will crash to $0.0596 (as a OTCPS stock) very soon from yesterday's low $0.115 (as a Nasdaq stock)! I'm flipping for 20% quick gain now before it is too late...
๐Ÿ‘๏ธ0
DFRANK1970 DFRANK1970 6 years ago
I'm so dang glad that I got out of anth last week with a profit. Wheeeeew!!!
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 6 years ago
Almost exactly like I predicted a couple of weeks ago ANTH crash to $0.115 today! Tomorrow it will be traded on the OTC market. We might see A Series Of New 52-week lows tomorrow due to today's Nasdaq De-listing event!

In the worst situation we might see it further crash to 0.04 then it will bounce back to 0.2 or higher. Perhaps 0.071 will be the Lowest price it could go tomorrow if the on-going sell-off continues like today! Anyway after ANTH finds out its true New Bottom it will quickly bounce back to 0.212 or higher based on the recent bouncing patterns plus its basic valuation...

If ANTH follow its peer's performance (RASH crash to 0.083 from its previous Bottom 0.16 after De-listing from NYSE to OTCQB market) then it will crash to 0.0596 tomorrow...

Anyway I ever warned all buyers here: don't buy ANTH above $0.31!

๐Ÿ‘๏ธ0
ClayTrader ClayTrader 6 years ago
* * $ANTH Video Chart 06-27-18 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0
TenKay TenKay 6 years ago
ANTH delisted from Nasdaq to OTC effective June 28, 2018.

http://otce.finra.org/DailyList
๐Ÿ‘๏ธ0
Inoviorulez Inoviorulez 6 years ago
Look it is being delisted. Good for you getting out early and catching it. Bad for everyone else still in Anthera
๐Ÿ‘๏ธ0
GreekSeas0ning GreekSeas0ning 6 years ago
POS CEO and garbage company/management. I played this ticker last summer for two Pumps then got out quick before their RS and shenanigans. Sad for all those who got fleeced thinking and believing in the product(s)/.

๐Ÿ‘๏ธ0
Value_Investor Value_Investor 7 years ago
The Pos Scam is heading onto $0.10xx in the coming days/weeks...

Nasdaq-Delisting will kick in anytime from now on... Usually this kind of downgrading crash the price down by -50%!

The well overdue Dissolution and Liquidation will be another very important Negative event...
๐Ÿ‘๏ธ0
enforcer1 enforcer1 7 years ago
ANTH President/CEO leaving - "Termination without Cause" ?
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 7 years ago
Yes. I sold out all my remaining shares today and made huge Quick profit! Be honest, today's ANTH performance is much much better than I expected (I thought $0.31 would be the top ceiling)! Congratulate to all today's and yesterday's very smart sellers who sold out this Pos Scam at Extremely Overvalued price levels! I'll buy this trash again when it hit $0.10xx after De-listing... Anyway its Bio-Tech peer (NSPR) is a much much better NYSE stock with huge upward potential plus very strong fundamentals! Another NYSE peer (RASF) is also one fire now with much much better fundamentals!
๐Ÿ‘๏ธ0
ClayTrader ClayTrader 7 years ago
* * $ANTH Video Chart 06-12-18 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0
enforcer1 enforcer1 7 years ago
I'm assuming you sold out now?
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
Kline I said yesterday, this stock is going to hit .50 then run to dollars. Mark this post. Reversal is in order.

$ANTH
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
.50 is coming to this stock this week. This is a chart play and it's being played to the "T" by many players. Could see a buck within a week or two. This is an exciting week and will surpass .31 by leaps and bounds this week alone.

$ANTH
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 7 years ago
Glad to make huge profit today by selling out the majority of my shares today! I'll continue to sell the rest 200K+ shares tomorrow at $0.31 ~ $0.24 to get rid of ANTH because it is Extremely Overvalued now and Extremely Overbought today! Then I'll wait to buy back all the shares at $0.1xxx very soon... De-listing and Downgrading will kick in as soon as this week...

Warning to all the buyers! Any price above $0.31 is Hyper Risk which will lead to 50% or more losses in the coming days/weeks...
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
We breached the MA50 today, looking forward to reaching the MA100 later in the week. Got a strong feeling that we may closed that down gap on this run. We have to get to $2.50 to complete the down gap. Chart reversal in motion here. Enjoy the ride. Should see a much greater jump in price tomorrow. Volume is here and the investment community have been alerted today. Watch them pounce on this stock tomorrow.
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
$ANTH all indicators pointing to this stock doubling or better this week. Over a buck within the next 2-3 weeks.
Enjoy the ride.
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
From whatsonthorold.com


Among 7 analysts covering Anthera Pharmaceuticals (NASDAQ:ANTH), 4 have Buy rating, 1 Sell and 2 Hold. Therefore 57% are positive. Anthera Pharmaceuticals had 21 analyst reports since August 13, 2015 according to SRatingsIntel. Piper Jaffray maintained Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) rating on Thursday, December 29. Piper Jaffray has โ€œOverweightโ€ rating and $1.35 target. The stock has โ€œBuyโ€ rating by Suntrust Robinson on Wednesday, September 9. Jefferies reinitiated Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) on Friday, February 19 with โ€œBuyโ€ rating. The company was maintained on Monday, June 26 by Jefferies. As per Tuesday, March 6, the company rating was maintained by Jefferies. The firm has โ€œHoldโ€ rating by Jefferies given on Sunday, August 6. On Thursday, August 13 the stock rating was upgraded by Zacks to โ€œHoldโ€. Citigroup downgraded the shares of ANTH in report on Thursday, December 29 to โ€œNeutralโ€ rating. The stock of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has โ€œBuyโ€ rating given on Wednesday, September 9 by SunTrust. Citigroup initiated the stock with โ€œBuyโ€ rating in Thursday, September 17 report. See Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) latest ratings:

12/03/2018 Broker: Piper Jaffray Rating: Sell Downgrade
06/03/2018 Broker: Jefferies Rating: Hold New Target: $2.0 Maintain
21/02/2018 Broker: Roth Capital Rating: Buy New Target: $10 Initiates Coverage On
13/02/2018 Broker: Jefferies Rating: Hold New Target: $1.75 Maintain
22/01/2018 Broker: Piper Jaffray Rating: Buy New Target: $4.0 Maintain

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. The company has market cap of $6.40 million. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of immunoglobulin A nephropathy. It currently has negative earnings.

The stock increased 6.30% or $0.0145 during the last trading session, reaching $0.2445. About 772,825 shares traded. Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has declined 86.78% since June 10, 2017 and is downtrending. It has underperformed by 99.35% the S&P500. Some Historical ANTH News: ; 12/03/2018 โ€“ Anthera to explore options after lead drugโ€™s trial failure; 06/03/2018 โ€“ Anthera Pharmaceuticals Deemed Compliant with Nasdaq Listing Criteria; 12/03/2018 โ€“ Anthera Pharma: Sollpura Did Achieve Secondary Endpoint of Coefficient of Nitrogen Absorption; 05/03/2018 โ€“ Anthera Pharmaceuticals 4Q Loss/Shr 73c; 12/03/2018 โ€“ Anthera Pharma: Anthera to Evaluate All Strategic Alternatives; 12/03/2018 โ€“ Anthera Pharma: Further Development of Sollpura to Be Discontinued; 05/03/2018 โ€“ Anthera Pharma: Phase 3 RESULT Study Completed Patient Dosing, Topline Data Expected March 2018; 05/03/2018 โ€“ ANTHERA PHARMACEUTICALS INC โ€“ QTRLY NET LOSS PER SHARE APPLICABLE TO COMMON STOCKHOLDERS $0.73; 12/03/2018 โ€“ Anthera Pharmaceuticals Plans to Evaluate the Full Data Outputs; 06/03/2018 โ€“ ANTHERA FILES PROSPECTUS FOR $100M MIXED SECURITIES SHELF
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
Positive earnings is expected this week, could propel this back over a buck in a hurry.
Watch a surprise pull off delaying Nasdaq delisting.
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 7 years ago
I bet $0.1 will be the new Final bottom before the company dissolution/liquidation or merger into another company even terrible Nasdaq De-listing news should not break down the rocket-hard Forever bottom $0.1! Its NYSE-peer did crash 50% anyway after the stock being downgraded to the OTCQB market from NYSE exchange.

Hopefully ANTH could hold the current temporary bottom $0.213 in the coming week so that I could sell out all my rest shares at $0.31 ~ $0.24! I'm selling my shares for nice profit to avoid the coming two terrible bad news --- Dissolution/Liquidation and OTC-Downgrading!
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
From www.tickerreport.com
Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share
Saturday, June 9th, 2018
Ethan Ryder

Equities analysts expect that Anthera Pharmaceuticals Inc (NASDAQ:ANTH) will post earnings per share of ($0.60) for the current quarter, according to Zacks. Zero analysts have made estimates for Anthera Pharmaceuticalsโ€™ earnings. The highest EPS estimate is ($0.55) and the lowest is ($0.64). Anthera Pharmaceuticals reported earnings per share of ($2.03) during the same quarter last year, which would indicate a positive year over year growth rate of 70.4%. The business is expected to announce its next quarterly earnings results on Wednesday, June 13th.

Receive News & Ratings for Anthera Pharmaceuticals Daily
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.


According to Zacks, analysts expect that Anthera Pharmaceuticals will report full year earnings of ($2.28) per share for the current financial year, with EPS estimates ranging from ($2.37) to ($2.19). For the next financial year, analysts expect that the firm will post earnings of ($1.78) per share, with EPS estimates ranging from ($2.02) to ($1.54). Zacks Investment Researchโ€™s earnings per share averages are an average based on a survey of analysts that follow Anthera Pharmaceuticals.
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 7 years ago
ANTH crashed to 0.236 right before the market close! Does that mean some bad news will be released on next Monday?

If the coming Nasdaq De-listing news does not kick in next week then we should see ANTH test and might break up the 20-Day MAL 0.26 which is a strong resistance since the previous bottom before very bad news was 0.2615!

IMO, there is no way to hit any price above 0.31 which is why I set up my selling target up to 0.31 from the lower end 0.23! Anything above 0.25 is a great selling price, not for buying because Liquidation or Dissolution plus De-listing will soon kick in! Not mention the on-going endless huge dilutions from the crap CEO and his insiders...
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
There's a $5.25 price target on $ANTH

Analysts Set Anthera Pharmaceuticals Inc $ANTH Price Target at $5.25 theolympiareport.com/?p=838550
๐Ÿ‘๏ธ0
Value_Investor Value_Investor 7 years ago
Yes. I've made some very nice gain today by selling over 100K shares at 0.24 ~ 0.25xx... ANTH might bounce over 0.26 as soon as Monday unless Nasdaq De-listing news kicks in!
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
Chart reversal, expect a run back to .50 then over a buck real soon.
Lots of accumulation. Love those bottom buster charts.

$ANTH
๐Ÿ‘๏ธ0
enforcer1 enforcer1 7 years ago
Looks like you got your selling range for a short while.

GL
๐Ÿ‘๏ธ0
Stockcaller Stockcaller 7 years ago
Eventually she has to go, looks to break .24 today. Looking good. Would love to see her breakout, I think it's coming next week.

$ANTH
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock